Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS
Arq. neuropsiquiatr; 75 (8), 2017
ABSTRACT Objective To investigate the impact of epidemiological and clinical factors on the benefit of riluzole in patients with amyotrophic lateral sclerosis (ALS). Methods The survival rate of 578 patients with ALS (1999-2011) was analyzed by descriptive statistics and Kaplan-Meier curves. Consider...
Esclerosis Amiotrófica Lateral/diagnóstico, Esclerosis Amiotrófica Lateral/tratamiento farmacológico, Esclerosis Amiotrófica Lateral/mortalidad, Brasil/epidemiología, Parálisis Bulbar Progresiva/diagnóstico, Electromiografía, Fármacos Neuroprotectores/uso terapéutico, Estudios Prospectivos, Riluzol/uso terapéutico, Factores Sexuales, Tasa de Supervivencia